IGF1 and Alzheimer disease: In the AD group, IGF-1 levels (2.02 ± 0.880), expressed as upper limit of normal (ULN), were significantly higher than those observed in the CD (0.66 ± 0.20, p = 0.006) and RD (0.66 ± 0.22, p = 0.001) groups.